---
title: "ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/71867e57-780d-5d7c-b5a9-79e5fab12dbe
json: https://whiteintel.dev/api/public/dossier/71867e57-780d-5d7c-b5a9-79e5fab12dbe
identifier: oo:GB-COH-08630390
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08630390`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/71867e57-780d-5d7c-b5a9-79e5fab12dbe  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/71867e57-780d-5d7c-b5a9-79e5fab12dbe  

## Ownership & control

### Owners / controllers

- **Director Alan Blazei** (beneficial owner) — https://whiteintel.dev/entity/c9084696-887e-4695-971a-a2c3865a8187
- **Mr Nigel Granville Page** (beneficial owner) — https://whiteintel.dev/entity/9543d77a-b100-5651-b4d8-022443324a49
- **Director James Karis** (beneficial owner) — https://whiteintel.dev/entity/d43bd369-7fa4-5364-9f9c-1f6552228cd1
- **Director Alan Blazei** (beneficial owner) — https://whiteintel.dev/entity/9255135f-ea42-5243-8f23-a059189e44e1
- **ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/888b7a73-642e-519e-80ae-0e53aca6a283
- **Mr Nigel Granville Page** (beneficial owner) — https://whiteintel.dev/entity/00032169-cd20-4107-970b-5d22a347aa27
- **Director James Karis** (beneficial owner) — https://whiteintel.dev/entity/b598b3f4-48c0-4a29-861a-4aef4d2d39ee
- **ICON CLINICAL RESEARCH (U.K.) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/8f9a0318-76be-59fa-ab33-15b9a7307b2f
- **ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/888b7a73-642e-519e-80ae-0e53aca6a283

### UBO chain (walk to the ultimate owner)

A **21-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08630390`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2013-07-30
- **Registered office:** 3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, United Kingdom
- **SIC:** 86900

### Officers

- FOX, Erina, Ms. — secretary · appointed 2017-07-27
- HOLMES, Simon — director · British · appointed 2017-07-27
- PAGE, Nigel Granville — secretary · British · appointed 2014-12-30 · resigned 2017-07-27
- SPICOLA, Brigid — secretary · appointed 2013-07-30 · resigned 2014-12-30
- ANDERSON, Neil David — director · British · appointed 2014-01-15 · resigned 2014-12-30
- BERRYMAN, David Robert — director · Us Citizen · appointed 2014-09-05 · resigned 2014-12-30
- BLAZEI, Alan Steven — director · American · appointed 2014-12-30 · resigned 2017-12-01
- FORD, Stephen Kelsey — director · British · appointed 2013-07-30 · resigned 2014-01-15
- GLEESON, Michael — director · Irish · appointed 2017-07-27 · resigned 2022-10-21
- KARIS, James Michael — director · American · appointed 2014-12-30 · resigned 2017-07-27
- PAGE, Nigel Granville — director · British · appointed 2016-08-24 · resigned 2018-06-08
- SHEEHAN, Alan — director · Irish · appointed 2017-07-27 · resigned 2026-04-08

### Beneficial owners (Persons with Significant Control)

- [Icon Clinical Research (U.K.) Limited](https://whiteintel.dev/entity/8f9a0318-76be-59fa-ab33-15b9a7307b2f) — 75–100% shares · corporate PSC · United Kingdom — since 2025-05-31
- [Icon Clinical Research (U.K.) No. 3 Limited](https://whiteintel.dev/entity/888b7a73-642e-519e-80ae-0e53aca6a283) — 75–100% shares · corporate PSC · United Kingdom — ceased 2025-05-31
- Mr Nigel Granville Page — significant influence or control · individual PSC · England — ceased 2017-07-19
- Director James Karis — significant influence or control as trust · individual PSC · England — ceased 2017-07-19
- Director Alan Blazei — significant influence or control · individual PSC · England — ceased 2017-07-19

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08630390
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08630390

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED** — https://whiteintel.dev/entity/71867e57-780d-5d7c-b5a9-79e5fab12dbe · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ICON CLINICAL RESEARCH (U.K.) NO. 2 LIMITED**. Human view: https://whiteintel.dev/entity/71867e57-780d-5d7c-b5a9-79e5fab12dbe · Structured JSON: https://whiteintel.dev/api/public/dossier/71867e57-780d-5d7c-b5a9-79e5fab12dbe._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._